Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer-Reference-Cited by-同舟云学术

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

Published:1992-01 Issue:10 Volume:46 Page:465-471
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Schally AV,Comaru-Schally AM,Gonzalez-Barcena D

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference38 articles.

1. Zoladex: A sustained-release monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer;Ahmann;J Clin Oncol,1987

2. New antagonists of LHRH: II. Inhibition and potentiation of LHRH by closely related analogues;Bajusz;Int J Peptide Protein Res,1988

3. Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6;Bajusz,1989

4. Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone;Bajusz,1989

5. National Cancer Institute Study of Luteinizing Hormone-Releasing Hormone Plus Flutamide Versus Luteinizing Hormone-Releasing Hormone Plus Placebo;Benson;Sem Oncol,1991

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting anticancer hyperfoods with graph convolutional networks;Human Genomics;2021-06-07

2. Androgen receptor antagonists for prostate cancer therapy;Endocrine-Related Cancer;2014-03-17

3. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas;The Prostate;2009-03-19

4. Evaluation of the in vitro and in vivo activity of the l-, d,l- and d-Cit6 forms of the LH-RH antagonist Cetrorelix (SB-75);International Journal of Peptide and Protein Research;2009-01-12

5. Effect of Leuprolide and Cetrorelix on Cell Growth, Apoptosis, and GnRH Receptor Expression in Primary Cell Cultures from Human Prostate Carcinoma;Cancer Investigation;2006-01